Brain Aneurysm Treatment Market Overview
Brain aneurysm or cerebral aneurysm is an abnormal lesion in the blood vessels of the brain which can cause health hazards and lead to death. It has the potential to rupture which can cause internal bleeding and lead to a stroke. The global brain aneurysm market report by Market Research Future (MRFR) considers historic events, news, and company investments for predicting an enumerated list of drivers, opportunities, and restraints for interested investors.
The global Brain Aneurysm Treatment Market is touted to grow at a CAGR of 5.4% during the forecast period between 2017 and 2023. Factors contributing to its occurrence include cigarette smoking, blood infections, injury or trauma, and others. Patients suffering from this condition of brain aneurysm can be diagnosed through multiple means or techniques, including magnetic resonance angiography (MRA), cerebral angiogram, computed tomography (CT) scan, computed tomography angiogram (CTA) scan, and many others.
Market Research Future (MRFR) asserts in its report that the global market is influenced by various key factors. This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector. Also, the presence of brain aneurysm in the family is another key driver of the market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4561
Brain Aneurysm Treatment Market Segmentation
The brain aneurysm treatment market segmentation is based in terms of condition, type, and end-user.
By type, the market divides into medication and surgery.
The surgery segment narrows down further into endovascular coiling, surgical clipping, flow diverter, and others. The flow diverter segment breaks down into silk flow diverter (SILK), pipeline embolization device, and surpass flow diverter (SURPASS).
The medication segment comprises calcium channel blockers, anti-seizure medications, antacids, antiemetics, analgesics, antihypertensives, stool softeners, and others.
By end-user, the market includes clinics, hospital, and others.
By condition, the market divides into ruptured and unruptured aneurysm.
Brain Aneurysm Treatment Market Regional Analysis
The Americas, the Middle East Africa (MEA), Europe, and Asia Pacific (APAC) are major regions profiled in the market report.
The Americas can reign over the global aneurysm treatment market and pegged to grow significantly in the forthcoming years. The growth is attributed to the increasing prevalence of brain aneurysm and inflated healthcare expenditure of nations in the region. Moreover, procurement of advanced diagnostic machines for discerning aneurysms or unwanted malformations in the brain by hospitals and clinics can bode well for the market. According to the 2017 report of Surgical Neurology International, nearly 10 million individuals have been diagnosed with brain aneurysm.
Brain Aneurysm Treatment Market Players
- Stryker
- Braun Melsungen AG
- MicroPort Scientific Corporation
- Medtronic
- Terumo Corporation
- Integra LifeSciences Corporation
- Johnson Johnson
- RAUMEDIC AG
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/brain-aneurysm-treatment-market-4561
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
